Academic JournalOpen Access

Mental Health Clinician

1 Papers Indexed in Blossom

Data updated October 28, 2025

Research Footprint

Mental Health Clinician has 1 tracked paper indexed in Blossom (2017) from 4 authors, most often covering Ketamine and Placebo, across Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD) and Bipolar Disorder.

Published Papers

Open Accessmeta

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

This literature review (2017) of randomised, placebo-controlled trials explores the effects of ketamine in treatment-resistant depression (TRD) and bipolar depression (BD). Ketamine reduced symptoms in both and is a promising compound for those who have found other treatments lacking.

Published: January 1, 2017
Journal: Mental Health Clinician
Authors: Grady, S. E., Marsh, T. A., Tenhouse, A., Klein, K.

Quick Facts

Papers Indexed: 1
h-Index: 27
Open Access: Yes
Publisher: American Association of Psychiatric Pharmacists
Country: United States
Website: Visit

Mental Health Clinician

Research Footprint

Published Papers

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

Quick Facts

Company

Product

Legal